Aetiology and management of hereditary aortopathy.

about

Non-coding RNA Contribution to Thoracic and Abdominal Aortic Aneurysm Disease Development and Progression.ACTA2 mutation and postpartum hemorrhage: a case report.Genetic diagnostics of inherited aortic diseases : Medical strategy analysis.

P2860

Q33804552-61F56B01-ED95-41C7-A0BE-CD7C583E4D7C Q47122250-2BDA49DD-EF57-4B93-9A66-341B0056ED36 Q48788951-E3686FFB-55A0-41EE-9499-B5D840496ABD

P2860

Aetiology and management of hereditary aortopathy.

Item

http://www.wikidata.org/entity/Q39094762

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Aetiology and management of hereditary aortopathy.

@en

Aetiology and management of hereditary aortopathy.

@nl

type

Item

label

Aetiology and management of hereditary aortopathy.

@en

Aetiology and management of hereditary aortopathy.

@nl

prefLabel

Aetiology and management of hereditary aortopathy.

@en

Aetiology and management of hereditary aortopathy.

@nl

P1476

Aetiology and management of hereditary aortopathy.

@en

P2093

Ilse Luyckx

http://www.w3.org/2001/XMLSchema#string

P2860

Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm/aortic dissection and patent ductus arteriosus

Mutations in myosin light chain kinase cause familial aortic dissections

Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta

Three arginine to cysteine substitutions in the pro-alpha (I)-collagen chain cause Ehlers-Danlos syndrome with a propensity to arterial rupture in early adulthood

Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome

Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and Moyamoya disease, along with thoracic aortic disease

Mechanotransduction and extracellular matrix homeostasis

A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2

Angiotensin II blockade and aortic-root dilation in Marfan's syndrome

Angiotensin II blockade reverses myocardial fibrosis in a transgenic mouse model of human hypertrophic cardiomyopathy

P2888

nrcardio.2016.211

P304

197-208

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRCARDIO.2016.211

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Bart L Loeys

A Verstraeten

P577

2017-01-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1008341216

http://www.w3.org/2001/XMLSchema#string

P698

28102232

http://www.w3.org/2001/XMLSchema#string

Aetiology and management of hereditary aortopathy.

about

P2860

P2860

Aetiology and management of hereditary aortopathy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698